中文版

About Us

Oceanpine Capital is an institutional growth equity investment company formed by seasoned entrepreneurs and sophisticated investors with 20 years of in-depth industry operational and business building experiences in both China and the US. With a perspective of achieving successful growth over the long term, Oceanpine partners visionary entrepreneurs to build world-class companies together over a period of years rather than on the short-term impact. Our profound industrial and business partners' network, resources and know-how not only enable us to discover truly proprietary companies with huge growth potential, but also provide tremendous value-added services to our entrepreneur partners and therefore foster their further growth.

We invest innovative and disruptive growth companies in both TMT and healthcare sectors, i.e., DeepTech areas, which are the driving force of the future economy in the New Norm. We believe in long term value investing, and provide strategic resources and operational support to our companies.

We invest across China and the world from our offices in Beijing,Shanghai,Hong Kong,and Silicon Valley.Our deal types are early-growth and growth capital oriented.

Our professional team consists of successful entrepreneurs, seasoned investors, sophisticated investment bankers and experienced industry executives and experts with proven track records in both China and the US. Meanwhile, we focus on attracting exceptionally talented people and rewarding excellence, initiative, independent thinking and integrity.

We have a strong company culture built upon the core values of "Excellence, Integrity, and Entrepreneurship", which we believe are a fundamental strength of our business.

Honors and Awards

2022-2023 China's Top 50 Best PE Investors

TOP50 Most Popular PE Investment Institutions among Entrepreneurs in 2023

Top 10 New Energy Industry Investment Institutions in 2023

2021 China’s Top30 Private Equity Voted by Limited Partners

2020 China’s Top50 Foreign Private Equity

2020 China’s Top100 Private Equity

China's Top 20 Investor in Enterprise Service /Healthcare Field in 2019-2020

China's Top10 PE Firm in 2020

China’s Top20 Dark Horse Fund in 2020

China’s Top100 Most Popular Investor among Eentrepreneurs in 2020

China’s Top50 Most Popular PE Firm among Entrepreneurs in 2020

Top10 Investment Firm of Deep-Tech Industry in 2020

Top50 Investor of Equity Investment in 2020

China's Best IC Investment Firm in 2020

China's Top10 Investment Firm in Biopharma Industry in 2020

China's Top 10 Investor in Biopharma Industry in 2020

China's Top10 PE Firm with the Most Growth Potential in 2020

China's Top20 Investor in Chip & Semiconductor in 2020

China‘s Top50 Foreign PE Firm in 2019

China’s Top10 Best Investment Case in AI and Big Data Industry in 2019

China's Most Innovative Investment Firm in 2019

The Most influential investor in 2019

China's Top 10 PE Firm with the Most Growth Potential in 2019

The Most Promising Investor in Deep-Tech in 2019

China's Innovation Leader of Economy in 2016

Top10 Figure of China's Economic Development in 2017

Investment Strategy

  • We invest in category-defining market leaders in DeepTech, early to late growth companies that distinguish themselves with applied disruptive technologies, proven innovative business model, with customer traction and / or in the early revenue stage.

VALUE PROPOSITION

  • Our seasoned, indigenous investment team, combined with in-depth industrial knowledge, network, and business relationships with top business enterprises in China and U.S., enable us to have significant advantage in deal creation, valuation negotiation, and bringing in customers and real business results to companies.

    Team's capital market insights and experience is another critical aspect of Oceanpine's competitive advantage. It enables us to strategize and build our exit and liquidity methods early in order to enhance DPI.

INVESTMENT FOCUS

Identify the category-defining market leaders in the sectors with huge potential of development
Prefer to invest sizeable and long-term capital in target companies to support long-term growth while providing significant value-added services
Focus on DeepTech: disruptive technologies enabled innovations in both TMT and healthcare sectors
Mainly invest in private companies while open to opportunities in some public companies w/ huge growth potential